Patents Represented by Attorney JHK Law
  • Patent number: 8349853
    Abstract: This invention generally relates to compositions and methods for cancer treatment and, in particular, to compositions able to interact (e.g., bind to) with MUC1 growth factor receptor or its ligands, and methods for treating the same. The invention also relates to assays or use of such compositions for the treatment of patients susceptible to or exhibiting symptoms characteristic of cancer or tumorigenesis. Other compositions of the present invention useful for the treatment or prevention of cancer or tumorigenesis include homologs, analogs, derivatives, enantiomers or functional equivalents. The present compositions can also be packaged in kits in some cases.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: January 8, 2013
    Assignee: Minerva Biotechnologies Corporation
    Inventor: Cynthia C. Bamdad
  • Patent number: 8344113
    Abstract: The invention provides a series of compositions, methods, kits, articles and species associated primarily with the diagnosis and/or treatment of cell proliferation, specifically cancer. Cell proliferation associated with aberrant expression of MUC1 is particularly focused upon. Mechanisms associated with MUC1 cell proliferation are discussed.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: January 1, 2013
    Assignee: Minerva Biotechnologies Corporation
    Inventor: Cynthia C. Bamdad
  • Patent number: 8329186
    Abstract: The application discloses a method of preventing immune cells from binding to other cells, which includes contacting the immune cells and the other cells with a composition comprising Bst2 antagonist.
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: December 11, 2012
    Assignee: Isu Abxis Co., Ltd
    Inventors: Myung Kim, Jay Chung, June-Young Park, Hyouna Yoo, Sang-Min Lee, Yoon-Seok Lee, Mison Koo, Sang-Ho Park
  • Patent number: 8324363
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Grant
    Filed: February 16, 2005
    Date of Patent: December 4, 2012
    Inventors: Sang Yup Lee, Nae Choon Yoo, So Young Yoo, Hyun Cheol Chung, Ki Chang Keum, Won Min Yoo, Ki Jun Jeong
  • Patent number: 8313483
    Abstract: Provided is an operating tool for organism, in particular, a microwave endoscope forceps. In terms of the operating tool for organism, provided is a multifunctional operating tool which has holding and scissors functions simultaneously, and may further perform coagulation (tissue fixation) by microwaves. The operating tool has no definite fulcrum, and has both the holding and scissors functions with a simple structure by deforming a long-track rod called beam. Two blades are insulated from each other so as to allow microwave current supply. With this structure, an operating tool having three functions, i.e., “a holding function”, “a coagulating function”, and “a cutting function” with a single tool may be developed.
    Type: Grant
    Filed: November 8, 2007
    Date of Patent: November 20, 2012
    Assignee: National University Corporation Shiga University of Medical Science
    Inventors: Makoto Hosaka, Tohru Tani, Yoshimasa Kurumi, Shigeyuki Naka
  • Patent number: 8247493
    Abstract: The invention relates to a long-acting formulation of biopharmaceutical, more specifically an aptamer therapeutics. A branched PEGylated aptamer or a hyaluronic acid (HA) derivative of which degradation in vivo is regulated is linked by the bioconjugation with biopharmaceutical to produce the long-action formulation.
    Type: Grant
    Filed: April 13, 2009
    Date of Patent: August 21, 2012
    Assignees: Postech Academy-Industry Foundation, Posco
    Inventors: Sei-Kwang Hahn, Hyun-Gu Kang, Sung-Ho Ryu, Jung-Kyu Park, Eun-Ju Oh
  • Patent number: 8231756
    Abstract: The present application discloses a composite pad structure that includes a substrate bonded to a plurality of discrete, spaced-apart, resilient elements engaged to at least one reinforcing structure.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: July 31, 2012
    Assignee: Applied FT Composite Solutions Inc.
    Inventor: Daniel Kim
  • Patent number: 8211263
    Abstract: A method for fabricating an air-filled cellular structure for use as a resilient cushion. The method includes providing a molding structure including a shelf substantially surrounding a depression, and a platform that fits within the depression and is selectively movable between a plurality of positions relative to the shelf, moving the platform to a preselected position relative to the shelf, wherein the preselected position corresponds to a substantially predetermined amount of air to be contained by the air-filled cellular structure, and using a vacuum device to draw air from within the depression.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: July 3, 2012
    Assignee: Applied FT Composite Solutions Inc.
    Inventor: Daniel Kim
  • Patent number: 8206698
    Abstract: The present application discloses a method of treating a disease that is treatable by therapeutic angiogenesis comprising administering to a needy subject an effective amount of a chimeric coiled coil molecule comprising a coiled-coil domain linked to a receptor binding domain of a ligand.
    Type: Grant
    Filed: March 19, 2010
    Date of Patent: June 26, 2012
    Assignee: Aprogen, Inc.
    Inventors: Gou Young Koh, Chung-Hyun Cho
  • Patent number: 8173395
    Abstract: The present invention relates to a bioadhesive derived from mussel. In particular, it relates to a novel Mytilus galloprovincialis foot protein type 5 (MGFP-5) and a recombinant protein that is a hybrid of MGFP-5 and foot protein type 1 (FP-1), where an adhesive protein with adhesive activity can be economically mass-produced to be used in place of chemical adhesives through the present invention.
    Type: Grant
    Filed: September 23, 2009
    Date of Patent: May 8, 2012
    Assignees: Postech Foundation, POSCO
    Inventors: Hyung Joon Cha, Dong Soo Hwang
  • Patent number: 8157947
    Abstract: The present invention is directed to a method and apparatus for manufacturing a composite, foam/fabric material for use as protective material in products, and utilizes an apparatus which includes a punch press with punches arranged in rows and correspondingly aligned dies for receiving the punches therethrough. The system operates by punching a sheet of foam material into a plurality of discrete foam elements which are transferred onto a heated fabric substrate, and retained thereon by heat bonding. The apparatus consists, in one preferred embodiment, of a clamp plate which clamps a sheet of foam material onto a die plate, and after a punching sequence, the sheet of foam material, along with the sheet of fabric material, are indexed downstream, and the process repeats.
    Type: Grant
    Filed: April 27, 2007
    Date of Patent: April 17, 2012
    Assignee: Applied FT Composite Solutions Inc.
    Inventor: Daniel Kim
  • Patent number: 8084242
    Abstract: Disclosed are a method and a medium for cultivating the marine dinoflagellate Dinophysis acuminata. The laboratory culture of D. acuminata causing diarrhetic shellfish poisoning, whose cultivation was known difficult, has been first established, thereby contributing to a better understanding of ecophysiology, biology and toxicology of Dinophysis species, as well as the evolution of dinoflagellate plastids.
    Type: Grant
    Filed: September 4, 2007
    Date of Patent: December 27, 2011
    Assignees: Industry-Academic Cooperation Foundation, Kunsan National University
    Inventors: Won Ho Yih, Hyung Seop Kim, Myung Gil Park, Jung-rae Rho
  • Patent number: 8067387
    Abstract: The present invention relates to a method for stimulating angiogenesis using by DKK2 and composition comprising the same. The DKK2 protein of the present invention showed stimulating activities of tube formation on HUVEC, promoting activity of the sprouting of arterial circle tissues and promoting activity of vascular development in the embryo of mouse. Therefore, it can be used as the therapeutics or functional health food for treating and preventing ischemic disease.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: November 29, 2011
    Assignee: Theragen Etex Co., Ltd
    Inventors: Young-Guen Kwon, Jeong-Ki Min, Chae-Ok Yun, Young-Myeong Kim
  • Patent number: 8067174
    Abstract: The present invention relates to a DNA polymerase immobilized by covalent bonding. More particularly, the present invention relates to an immobilized DNA polymerase whose activity is maximally preserved by masking the active site of the DNA polymerase and optimizing interaction of the masked molecule to the substrate material. In one embodiment, the average activity of the immobilized DNA polymerase is more than about 10% relative to that of the solution phase DNA polymerase. Further provided by the invention are methods and kits for performing polymerase chain reactions (PCR).
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: November 29, 2011
    Assignee: Ahram Biosystems Inc.
    Inventors: Hyun Jin Hwang, Jeong Hee Kim
  • Patent number: 8053215
    Abstract: The present invention provides a nucleic acid sequence amplification method and apparatuses thereof that are simple in the design and easy to miniaturize and integrate into complex apparatuses, with capability of using DNA polymerases that are not thermostable. In the present invention, a plurality of heat sources are combined to supply heat to, or remove heat from specific regions of the sample such that a specific spatial temperature distribution is maintained inside the sample by locating a relatively high temperature region lower in height than a relatively low temperature region.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: November 8, 2011
    Assignee: Ahram Biosystems, Inc.
    Inventors: Hyun Jin Hwang, Jeong Hee Kim, Kyunghoon Jeong
  • Patent number: 8029990
    Abstract: The subject of the present invention is to provide a microarray for introducing nucleic acid, the microarray capable of introducing and expressing nucleic acid into cells simply by adding the nucleic acid onto a plate and the like, and then seeding the cells thereon and culturing them without adding a nucleic acid-introducing reagent or additives. The subject is achieved by preparing the microarray including atelocollagen, a gene-introducing agent and nucleic acid on a plate and the like for the introduction of nucleic acid. The nucleic acid can be introduced into a cell by seeding cells into which nucleic acids are introduced on the microarray and culturing them without the need of preparing a mixture of viral vectors, nucleic acids and a nucleic acid-introducing agent after culturing cells or the need of adding a nucleic acid-introducing agent and additives.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: October 4, 2011
    Assignee: Koken Co., Ltd.
    Inventors: Kimi Honma, Takahiro Ochiya
  • Patent number: 8008448
    Abstract: The present application discloses monoclonal antibody against cotinine and nicotine.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: August 30, 2011
    Assignee: National Cancer Center
    Inventors: Sunyoung Park, Junho Chung, Dohoon Lee, Jae-Gahb Park
  • Patent number: 8003093
    Abstract: The present invention relates to a B cell-based vaccine loaded with the ligand of natural killer T cell and antigen for the prevention and treatment of disease, more precisely, an immunotherapeutic and prophylactic vaccine mediated by B cells loaded with ?-galactosylceramide, a kind of glycolipid which can stimulate natural killer T cells. A vaccine composition of the present invention can be effectively used as an antitumor immunotherapeutic agent. B cells therein, which are easily obtainable compared with dendritic cells, not only induce a similar level of cytotoxic T lymphocyte response to that of the conventional dendritic cell-based vaccine but also have a prophylactic and therapeutic effect on solid tumor and metastatic tumor.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: August 23, 2011
    Assignee: Seoul National University Industry Foundation
    Inventors: Chang-Yuil Kang, Yeonseok Chung, Hyun-Jeong Ko, Yeon-Jeong Kim, Byung-Seok Kim, Sung-Youl Ko
  • Patent number: 7999070
    Abstract: The present invention relates to a screening method for RNA specific binding peptide using alpha-helical peptides. The screening method for RNA specific binding peptide of the present invention using alpha-helical peptides enables the selection of a peptide having strong binding capacity to a specific RNA having particular morphology and nucleotide sequence and the investigation of functions of RNA using the selected peptides, and is very useful for the production of a new drug using synthetic peptide having more powerful and specific binding capacity to RNA than those of natural peptides.
    Type: Grant
    Filed: July 14, 2006
    Date of Patent: August 16, 2011
    Assignee: Seoul National University Industry Foundation
    Inventor: Jaehoon Yu
  • Patent number: 7964393
    Abstract: The present invention relates to a novel constitutive promoter of plant, particularly to a putative lipase promoter Lip3 derived from Arabidopsis, a method for isolating the same, a recombinant expression vector containing the same and a use of the same for improving traits of a farm product. The constitutive promoter of the present invention can be applied to induce a constitutive gene expression such as herbicide resistance gene and reporter gene, because it can express a foreign gene regardless of its expression site. In addition, it can be widely used to develop a transgenic plant improving its useful trait.
    Type: Grant
    Filed: July 14, 2009
    Date of Patent: June 21, 2011
    Assignee: Korean Rural Development Administration
    Inventors: Sang-Ho Kang, Teresa Lee, Young-Mi Kim, Sun-Hwa Ha, Seok-Cheol Suh